Diagnos Laboratorium Utama Tbk. vs Sawit Sumbermas Sarana Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume), while Sawit Sumbermas Sarana Tbk trades at Rp910 (market cap 8.38T, 3.18M 24h volume). The key difference: Sawit Sumbermas Sarana Tbk is far larger — about 27.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Sawit Sumbermas Sarana Tbk is more actively traded (3.18M versus 22.7K). Which is the better fit depends on your goals.
| DGNS | SSMS | |
|---|---|---|
Market Cap | 308B | 8.38T |
Volume | 22.7K | 3.18M |
Lot | 227 | 31.83K |
Turnover | 5.17M | 2.88B |
Average Price | 227.59 | 905.64 |
Value | 5.17M | 2.88B |
Indicative Equilibrium Price | 230 | 890 |
Indicative Equilibrium Volume | 110 | 204 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.
Read more on SSMS →